Duluth Holdings Inc. to Report Third Quarter 2018 Financial Results on December 6
MOUNT HOREB, Wis., Nov. 19, 2018 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading”) (NASDAQ: DLTH), […]
Aeterna Zentaris (AEZS) Receives Positive CHMP Opinion of Macimorelin for Diagnosis of Adult Growth Hormone Deficiency
CHARLESTON, S.C., Nov. 19, 2018 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS), announced the Committee for Medicinal Products for […]
AgPlenus, a subsidiary of Evogene, to Present at the 2nd Annual AgChem & Technology Europe Conference
Boaz Inbal, VP R&D, will present AgPlenus’ unique approach for biology-driven discovery and introduce AgPlenus’ vision and pipeline REHOVOT, Israel, […]
Capitala Group Announces Growth Partnership with Visible Body
CHARLOTTE, N.C., Nov. 19, 2018 (GLOBE NEWSWIRE) — Capitala Group (“Capitala” or the “Company”), a provider of capital to lower […]
Fortress Biotech Announces Agreement to Sell Its Majority Stake in National Holdings Corporation to NHC Holdings, LLC, a wholly-owned subsidiary of B. Riley Financial
NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, […]
B. Riley Financial Enters Agreement to Purchase Fortress Biotech’s Stake in National Holdings
Acquires 24 percent of National Holdings’ outstanding sharesUp to an additional 32 percent of shares to be purchased following FINRA […]
Gentex Appoints Brian Walker to Board of Directors
ZEELAND, Mich., Nov. 19, 2018 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, […]
BrainStorm Cell Therapeutics Announces Submission of IND for NurOwn® in Progressive Multiple Sclerosis
NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative autologous […]
Minerva Neurosciences Announces Results of Dose Escalation Study Evaluating Roluperidone (MIN-101) Administered at Supra-Therapeutic Doses in Healthy Volunteers
Findings suggest expanded therapeutic window and significantly improved cardiovascular safety margin compared to formulation used in Phase 2b trial […]
Dermira to Present at Evercore ISI HealthCONx Conference
MENLO PARK, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) — Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech […]
